Genitourinary Cancers

• ESMO E-Learning: Sexuality and Intimacy after Cancer
• Nivolumab Benefit For MMR-Deficient Patients Extends Past Colorectal Cancer
• Optimal first-line treatment in mCRPC after either chemo or ARI in mHSPC
• Is there an optimal sequencing strategy in mCRPC?
• Radiation oncology perspective
• Partial versus radical nephrectomy: 10- year long-term survival among patients with Wilms tumour
• Neutrophil-to-lymphocyte ratio is a useful biomarker for predicting worse clinical outcome in chemo-resistant urothelial carcinoma patients treated...
• Long-term outcomes of bladder preservation in muscle-invasive bladder cancer patients
• An outcome analysis of robotassisted radical nephroureterectomy with extended template lymphadenectomy for upper tract urothelial carcinoma
• Apalutamide (APA) plus androgen deprivation therapy (ADT) for metastatic castration-sensitive prostate cancer (mCSPC): Analysis of pain and fatigue...
• Efficacy and safety of darolutamide in non-metastatic castration-resistant prostate cancer (nmCRPC) in the ARAMIS trial
• What is the best first-line therapy for metastatic castration-sensitive prostate cancer in 2019? A network meta-analysis
• Long term outcomes of 2-weekly docetaxel in metastatic high-volume hormone sensitive prostate cancer
• The effect of radium-223 therapy in agent orange related veterans with metastatic castrate resistance prostate carcinoma (CRPC)
• Treatment pattern and outcomes of radium-223 (Ra223) in metastatic castration resistant prostate cancer (mCRPC): Retrospective cohort analysis from...
• Population-based validation of the risk stratification among prostate cancer patients
• Adjuvant axitinib in Asian vs non-Asian patients with metastatic renal cell carcinoma (mRCC): ATLAS trial subgroup analysis
• Immunotherapy with nivolumab in metastatic renal cell carcinoma patients in India: Bringing a change in clinical practice
• An observational retrospective real-world study of sarcomatoid renal cell carcinoma (sRCC) patients in an Asian cancer centre
• Targeting epithelial-mesenchymal transition (EMT), novel strategy to delay resistance or re-sensitize renal cancer to Sunitinib
• Radiologic and pathologic tumour size variation in localized renal cell carcinoma and its implications
• Metastatic carcinoma gall bladder: A clinicoepidemiological profile of Indian patients
• Comparative analysis of first-line immune checkpoint inhibitor versus carboplatin-based chemotherapy for cisplatin-ineligible metastatic urothelial...
• Does tumor grade really improve the prognostic ability of the staging system for men with penile cancer: A SEER database analysis
• EV-301: A phase III trial in progress evaluating enfortumab vedotin versus chemotherapy in patients with locally advanced or metastatic urothelial...

• « Previous
• 1
• 2
• ...
• 83
• Next »